Annual ROE
-18.19%
-34.08%-214.47%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual return on equity is -18.19%, with the most recent change of -34.08% (-214.47%) on December 31, 2023.
- During the last 3 years, ITOS annual ROE has fallen by -6.42% (-54.55%).
- ITOS annual ROE is now -129.23% below its all-time high of 62.22%, reached on December 31, 2019.
Performance
ITOS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-20.11%
-2.10%-11.66%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly return on equity is -20.11%, with the most recent change of -2.10% (-11.66%) on September 30, 2024.
- Over the past year, ITOS quarterly ROE has dropped by -2.02% (-11.17%).
- ITOS quarterly ROE is now -130.23% below its all-time high of 66.53%, reached on June 30, 2022.
Performance
ITOS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ITOS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -214.5% | -11.2% |
| 3 y3 years | -54.5% | -542.0% |
| 5 y5 years | +84.8% | - |
ITOS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -137.1% | at low | -130.2% | +11.1% |
| 5 y | 5-year | -129.2% | at low | -130.2% | +55.4% |
| alltime | all time | -129.2% | +84.8% | -130.2% | +55.4% |
ITeos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -20.11%(+11.7%) |
| Jun 2024 | - | -18.01%(-20.4%) |
| Mar 2024 | - | -22.62%(+25.0%) |
| Dec 2023 | -18.19%(-214.5%) | -18.09%(+86.1%) |
| Sep 2023 | - | -9.72%(+119.9%) |
| Jun 2023 | - | -4.42%(-346.9%) |
| Mar 2023 | - | 1.79%(-88.5%) |
| Dec 2022 | 15.89% | 15.52%(-66.4%) |
| Sep 2022 | - | 46.24%(-30.5%) |
| Jun 2022 | - | 66.53%(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 64.68%(+15.1%) |
| Dec 2021 | 48.98%(-516.1%) | 56.20%(+1135.2%) |
| Sep 2021 | - | 4.55%(-121.9%) |
| Jun 2021 | - | -20.80%(+24.0%) |
| Mar 2021 | - | -16.78%(+2.7%) |
| Dec 2020 | -11.77%(-118.9%) | -16.34%(-18.0%) |
| Sep 2020 | - | -19.93%(-36.5%) |
| Jun 2020 | - | -31.40%(-30.3%) |
| Mar 2020 | - | -45.08%(-172.5%) |
| Dec 2019 | 62.22%(-151.9%) | 62.22% |
| Dec 2018 | -119.96% | - |
FAQ
- What is iTeos Therapeutics annual return on equity?
- What is the all time high annual ROE for iTeos Therapeutics?
- What is iTeos Therapeutics annual ROE year-on-year change?
- What is iTeos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly ROE year-on-year change?
What is iTeos Therapeutics annual return on equity?
The current annual ROE of ITOS is -18.19%
What is the all time high annual ROE for iTeos Therapeutics?
iTeos Therapeutics all-time high annual return on equity is 62.22%
What is iTeos Therapeutics annual ROE year-on-year change?
Over the past year, ITOS annual return on equity has changed by -34.08% (-214.47%)
What is iTeos Therapeutics quarterly return on equity?
The current quarterly ROE of ITOS is -20.11%
What is the all time high quarterly ROE for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly return on equity is 66.53%
What is iTeos Therapeutics quarterly ROE year-on-year change?
Over the past year, ITOS quarterly return on equity has changed by -2.02% (-11.17%)